NGAL, measured either in serum or urine, can potentially predict AKI 24–48 h before the diagnosis of creatinine-based AKI and to detect subclinical AKI (i.e., NGAL-positive but creatinine-negative), which is associated with subsequent need for RRT or death [86–89]. Here, LCN2 is linked to acute kidney injury.